Chicago Partners Investment Group LLC Adverum Biotechnologies, Inc. Transaction History

Chicago Partners Investment Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.08 - $3.6 $95,994 - $166,143	-46,151 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$3.36 - $10.56 $75,284 - $236,607	22,406 Added 94.36%	46,151 $112,000
Q1 2021 Apr 28, 2021	BUY	$9.26 - $14.36 $88,238 - $136,836	9,529 Added 67.03%	23,745 $237,000
Q4 2020 Jan 27, 2021	BUY	$9.84 - $14.26 $139,885 - $202,720	14,216 New	14,216 $190,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.